1Mitophagy in acute central nervous system injuries:regulatory mechanisms and therapeutic potentialsSiyi Xu，Junqiu Jia，Rui Mao，Xiang Cao，Yun XuReviews2437-2453
2Targeting harmful effects of non-excitatory amino acids as an alternative therapeutic strategy to reduce ischemic damageVictoria Jiménez Carretero，Iris Álvarez-Merz，Jorge Hernández-Campano，Sergei A.Kirov，Jesús M.Hernández-GuijoReviews2454-2463
3Crosstalk among canonical Wnt and Hippo pathway members in skeletal muscle and at the neuromuscular junctionSaid Hashemolhosseini，Lea GesslerReviews2464-2479
4Olfactory receptors in neural regeneration in the central nervous systemRafael Franco，Claudia Garrigós，Toni Capó，Joan Serrano-Marín，Rafael Rivas-Santisteban，Jaume LilloReviews2480-2494
6Acquired sensorineural hearing loss,oxidative stress,and microRNAsDesmond A.Nunez，Ru C.GuoReviews2513-2519
7Glucocorticoid receptor signaling in the brain and its involvement in cognitive functionChonglin Su，Taiqi Huang，Meiyu Zhang，Yanyu Zhang，Yan Zeng，Xingxing ChenReviews2520-2537
8Nanocarrier-mediated siRNA delivery:a new approach for the treatment of traumatic brain injury-related Alzheimer's diseaseJie Jin，Huajing Zhang，Qianying Lu，Linqiang Tian，Sanqiao Yao，Feng Lai，Yangfan Liang，Chuanchuan Liu，Yujia Lu，Sijia Tian，Yanmei Zhao，Wenjie RenReviews2538-2555
9Blood diagnostic and prognostic biomarkers in amyotrophic lateral sclerosisYongting Lv，Hongfu LiReviews2556-2570
10Spinal cord injury regenerative therapy development:integration of design of experimentsYuji Okano，Hideyuki Okano，Yoshitaka KasePerspectives2571-2573
11Many faces of neuronal activity manipulation in DrosophilaAmber Krebs，Steffen Kautzmann，Christian KlämbtPerspectives2574-2576
12Apolipoprotein E elicits target-directed miRNA degradation to maintain neuronal integrityJiazi Tan，Chin-Tong OngPerspectives2577-2578
13Cellular models of stress resistance may pave ways to fight neurodegenerative diseasesThu Nguyen Minh Pham，Christian BehlPerspectives2579-2580
14Crosstalk between androgen signaling and the chemokine receptor CXCR4:a novel strategy to promote myelin regenerationMarianne Bardy-Lagarde，Narimène Asbelaoui，Abdel Mouman GhoumariPerspectives2581-2582
15Translational challenges in amyotrophic lateral sclerosis therapy with macrophage migration inhibitory factorLeenor Alfahel，Aleksandar Rajkovic，Adrian IsraelsonPerspectives2583-2584
16Soluble epoxide hydrolase:a next-generation drug target for Alzheimer's disease and related dementiasAndrew Gregory，Chengyun Tang，Fan FanPerspectives2585-2586
17Tale of mitochondria and mitochondria-associated ER membrane in patient-derived neuronal models of Wolfram syndromeLaetitia Aubry，Timothy Barrett，Sovan SarkarPerspectives2587-2588
18Disruption of neuronal actin barrier promotes the entry of disease-implicated proteins to exacerbate amyotrophic lateral sclerosis pathologyMikio Shimizu，Tatsusada OkunoPerspectives2589-2590
19Emerging potential of progranulin-dependent SorCS2 signaling in healthy and diseased nervous systemsAlena Salasova，Anders NykjærPerspectives2591-2593
20Syndecans in Alzheimer's disease:pathogenetic mechanisms and potential therapeutic targetsCarmela Rita Balistreri，Roberto MonasteroPerspectives2594-2595
